These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7720764)

  • 21. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the severity of alcoholic liver cirrhosis and the metabolism of caffeine in 226 patients.
    Bechtel YC; Haffen E; Lelouët H; Brientini MP; Paintaud G; Miguet JP; Bechtel PR
    Int J Clin Pharmacol Ther; 2000 Oct; 38(10):467-75. PubMed ID: 11073287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis.
    Lelouët H; Bechtel YC; Paintaud G; Brientini MP; Miguet JP; Bechtel PR
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):25-32. PubMed ID: 11204934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors.
    Rasmussen BB; Brix TH; Kyvik KO; Brøsen K
    Pharmacogenetics; 2002 Aug; 12(6):473-8. PubMed ID: 12172216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice.
    Chaloupka K; Santostefano M; Goldfarb IS; Liu G; Myers MJ; Tsyrolv IB; Gelboin HV; Krishnan V; Safe S
    Carcinogenesis; 1994 Dec; 15(12):2835-40. PubMed ID: 8001243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking impact on CYP1A2 activity in a group of patients with schizophrenia.
    Bozikas VP; Papakosta M; Niopas I; Karavatos A; Mirtsou-Fidani V
    Eur Neuropsychopharmacol; 2004 Jan; 14(1):39-44. PubMed ID: 14659985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man.
    Chen Y; Kang Z; Yan J; Yang GP; Tan ZR; Zhou G; Ouyang DS
    J Ethnopharmacol; 2010 Oct; 132(1):213-8. PubMed ID: 20723593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH; Nierenberg DW; Bresnick E
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine.
    Vistisen K; Poulsen HE; Loft S
    Carcinogenesis; 1992 Sep; 13(9):1561-8. PubMed ID: 1394840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pantoprazole lacks induction of CYP1A2 activity in man.
    Hartmann M; Zech K; Bliesath H; Steinijans VW; Koch H; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):159-64. PubMed ID: 10235417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.
    Carrillo JA; Christensen M; Ramos SI; Alm C; Dahl ML; Benitez J; Bertilsson L
    Ther Drug Monit; 2000 Aug; 22(4):409-17. PubMed ID: 10942180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats.
    Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS
    Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians.
    Welfare MR; Aitkin M; Bassendine MF; Daly AK
    Pharmacogenetics; 1999 Jun; 9(3):367-75. PubMed ID: 10471069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2.
    Matthaei J; Tzvetkov MV; Strube J; Sehrt D; Sachse-Seeboth C; Hjelmborg JB; Möller S; Halekoh U; Hofmann U; Schwab M; Kerb R; Brockmöller J
    Clin Pharmacol Ther; 2016 Dec; 100(6):606-616. PubMed ID: 27509179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise.
    Vistisen K; Loft S; Poulsen HE
    Adv Exp Med Biol; 1991; 283():407-11. PubMed ID: 2069014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human cytochrome P4501A2.
    Landi MT; Sinha R; Lang NP; Kadlubar FF
    IARC Sci Publ; 1999; (148):173-95. PubMed ID: 10493258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.
    Sachse C; Brockmöller J; Bauer S; Roots I
    Br J Clin Pharmacol; 1999 Apr; 47(4):445-9. PubMed ID: 10233211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus.
    Ayalogu EO; Snelling J; Lewis DF; Talwar S; Clifford MN; Ioannides C
    Biochim Biophys Acta; 1995 Oct; 1272(2):89-94. PubMed ID: 7548239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
    Eugster HP; Probst M; Würgler FE; Sengstag C
    Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.